Following the meeting, FDA updated the healthcare professional labeling for Lotronex and required the drug's maker, Glaxo Wellcome, to distribute a medication guide that warned patients about the risks associated with the drug. After meeting with the FDA today, Glaxo Wellcome informed the agency that it will voluntarily withdraw Lotronex from the market. All Rights Reserved. Get Your Medifocus Medguide Research Your Illness Visit our Medcenter and get your Medifocus Guide , trustworthy medical information specifically about your health condition. Bookstore Visit our IBD Bookstore and find books on the latest treatments and remedies for your illness.
Current members login here .
Get our best features delivered directly to you. All rights reserved.